Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Apoptosis and tumor inhibition induced by human chorionic gonadotropin beta in mouse breast carcinoma.

Authors: Shi, SQ  Xu, L  Zhao, G  Yang, Y  Peng, JP 
Citation: Shi SQ, etal., J Mol Med. 2006 Nov;84(11):933-41. Epub 2006 Aug 5.
Pubmed: (View Article at PubMed) PMID:16924466
DOI: Full-text: DOI:10.1007/s00109-006-0085-x

For many breast cancer patients, human chorionic gonadotropin beta (hCGbeta), which is a subunit of a hormone produced by the trophoblast and is essential for maintaining pregnancy, is expressed in the breast cancer cells. However, the mechanism as to how the CGbeta in cell affects the cancer development is not very clear. Mouse breast carcinoma 4T1 with stably hCGbeta expression (4T1-hCGbeta) was established and transplanted into the Balb/c mouse abdominal mammary gland. hCGbeta suppressed breast cancer cell viability in vitro, and dramatically inhibited tumor growth and attenuated tumor vessel formation in vivo. An 86-88% reduction in tumor volume in animals injected with breast cancer expressing hCGbeta, as opposed to those injected with breast cancer without hCGbeta expression, was observed. The production of p21 was promoted by hCGbeta, whereas the Cdk2 was decreasing. These indicate that p21 signal pathway is involved in this process. Significant apoptosis was also detected in hCGbeta-expressing breast cancer cells as well as the enhancement of Bax protein expression. Moreover, hCGbeta blocked the blood vessels formation by inhibiting the expression of MMP9 and VEGF. Further hormone secretion analyses show that the anti-tumor activity induced by hCGbeta is not related to the endocrine function.

Annotation

Disease Annotations
Objects Annotated

Additional Information

 
RGD Object Information
RGD ID: 2293558
Created: 2008-06-04
Species: All species
Last Modified: 2008-06-04
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.